Lucira Health to Participate in William Blair 41st Annual Growth Stock Conference

NEXT STORY
Sean Lavin, MD, Joins Progenity as Vice President, Business Development, Strategy, and Investor Relations
PREV STORY
Intranasal Drug and Vaccine Market 2028 – Insights on Key Trends, COVID-19 Impact, Value Chain Analysis, Strategic Initiatives, and Future Outlook: Adroit Market Research
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

FDA expedites review of Novartis drug Promacta® for first-line severe aplastic anemia (SAA)

Promacta receives FDA Priority Review for first-line treatment of SAA based on data showing ...

author_avatar
NASDAQ Market News

ICU Medical, Inc. Announces Time of Third Quarter 2016 Earnings Call

SAN CLEMENTE, Calif., Oct. 17, 2016 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a ...

author_avatar
NASDAQ Market News

Heat Biologics to Present at PIONEERS 2017 Presented by Joseph Gunnar & Co.

DURHAM, N.C., April 26, 2017 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. (“Heat”) (Nasdaq:HTBX), a ...

author_avatar
NASDAQ Market News